[
  {
    "ts": null,
    "headline": "Equity Markets Close Lower After Job Openings Data, Consumer Confidence Report",
    "summary": "US benchmark equity indexes closed lower on Tuesday, after June's lower-than-expected job openings a",
    "url": "https://finnhub.io/api/news?id=440c00d07af103e098cd3d47b542c590444a7ba75aae6ebf22d5443c43903d0a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753821374,
      "headline": "Equity Markets Close Lower After Job Openings Data, Consumer Confidence Report",
      "id": 136130478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes closed lower on Tuesday, after June's lower-than-expected job openings a",
      "url": "https://finnhub.io/api/news?id=440c00d07af103e098cd3d47b542c590444a7ba75aae6ebf22d5443c43903d0a"
    }
  },
  {
    "ts": null,
    "headline": "Equity Markets Lower After June Job Data, Consumer Confidence Beat",
    "summary": "US benchmark equity indexes are on track to close lower on Tuesday, as US job openings in June fell",
    "url": "https://finnhub.io/api/news?id=0855e8ee7259cc5b6ee8b58fbfa7a03579744818a81b4aa3aa2c0a6d54429fc3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753818380,
      "headline": "Equity Markets Lower After June Job Data, Consumer Confidence Beat",
      "id": 136130480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes are on track to close lower on Tuesday, as US job openings in June fell",
      "url": "https://finnhub.io/api/news?id=0855e8ee7259cc5b6ee8b58fbfa7a03579744818a81b4aa3aa2c0a6d54429fc3"
    }
  },
  {
    "ts": null,
    "headline": "Incyte (INCY) Stock Trades Up, Here Is Why",
    "summary": "Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 10.4% in the afternoon session after the company reported second-quarter financial results that beat analyst expectations and raised its full-year guidance for its top-selling drug, Jakafi. The specialty drugmaker posted quarterly revenue of $1.22 billion, a significant 17.3% increase from the previous year, which surpassed the consensus estimate of $1.15 billion. Its adjusted profit of $1.57 per share also came in ahead",
    "url": "https://finnhub.io/api/news?id=010e4fb9fdcd6af6876a62feaf9dc42f198b8b4a88e28f57c914390cb222e41b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753814451,
      "headline": "Incyte (INCY) Stock Trades Up, Here Is Why",
      "id": 136130889,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 10.4% in the afternoon session after the company reported second-quarter financial results that beat analyst expectations and raised its full-year guidance for its top-selling drug, Jakafi. The specialty drugmaker posted quarterly revenue of $1.22 billion, a significant 17.3% increase from the previous year, which surpassed the consensus estimate of $1.15 billion. Its adjusted profit of $1.57 per share also came in ahead",
      "url": "https://finnhub.io/api/news?id=010e4fb9fdcd6af6876a62feaf9dc42f198b8b4a88e28f57c914390cb222e41b"
    }
  },
  {
    "ts": null,
    "headline": "INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales",
    "summary": "Incyte reports better-than-expected second-quarter 2025 results, beating both earnings and revenue estimates, driven by strong Jakafi and Opzelura sales.",
    "url": "https://finnhub.io/api/news?id=0a22626ea29ce760ae708c006316bb25dc208e0dac9d2f2f1dc14006ab868855",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753803900,
      "headline": "INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales",
      "id": 136119869,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Incyte reports better-than-expected second-quarter 2025 results, beating both earnings and revenue estimates, driven by strong Jakafi and Opzelura sales.",
      "url": "https://finnhub.io/api/news?id=0a22626ea29ce760ae708c006316bb25dc208e0dac9d2f2f1dc14006ab868855"
    }
  },
  {
    "ts": null,
    "headline": "Incyte Corporation (INCY) Q2 2025 Earnings Call Transcript",
    "summary": "Incyte Corporation (NASDAQ:INCY) Q2 2025 Earnings Conference Call July 29, 2025 8:00 AM ETCompany ParticipantsChristiana Stamoulis - Executive VP &amp;...",
    "url": "https://finnhub.io/api/news?id=5e7072b88d6945c1aa3de28d9209ec875f4789359fa63eb40ff10f143687d104",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753795991,
      "headline": "Incyte Corporation (INCY) Q2 2025 Earnings Call Transcript",
      "id": 136119933,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "INCY",
      "source": "SeekingAlpha",
      "summary": "Incyte Corporation (NASDAQ:INCY) Q2 2025 Earnings Conference Call July 29, 2025 8:00 AM ETCompany ParticipantsChristiana Stamoulis - Executive VP &amp;...",
      "url": "https://finnhub.io/api/news?id=5e7072b88d6945c1aa3de28d9209ec875f4789359fa63eb40ff10f143687d104"
    }
  },
  {
    "ts": null,
    "headline": "Incyte Corporation 2025 Q2 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Incyte Corporation in conjunction with their 2025 Q2 earnings call.",
    "url": "https://finnhub.io/api/news?id=3792e36290d7b1818e2147e07868a86a678c89520c63d4ed45948b8611622a77",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753795883,
      "headline": "Incyte Corporation 2025 Q2 - Results - Earnings Call Presentation",
      "id": 136119935,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "INCY",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Incyte Corporation in conjunction with their 2025 Q2 earnings call.",
      "url": "https://finnhub.io/api/news?id=3792e36290d7b1818e2147e07868a86a678c89520c63d4ed45948b8611622a77"
    }
  },
  {
    "ts": null,
    "headline": "Incyte (INCY) Reports Q2 Earnings: What Key Metrics Have to Say",
    "summary": "While the top- and bottom-line numbers for Incyte (INCY) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=0db7d308d13769e35f5224b4e5b0db784922d55fa0e10d4cb97901a8c6c10a6c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753795804,
      "headline": "Incyte (INCY) Reports Q2 Earnings: What Key Metrics Have to Say",
      "id": 136119870,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for Incyte (INCY) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=0db7d308d13769e35f5224b4e5b0db784922d55fa0e10d4cb97901a8c6c10a6c"
    }
  },
  {
    "ts": null,
    "headline": "Incyte (INCY) Surpasses Q2 Earnings and Revenue Estimates",
    "summary": "Incyte (INCY) delivered earnings and revenue surprises of +12.95% and +5.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=76cf5b8634ecb133114ed0095071805ccbdfa884589707a7d3b8281f914940cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753791601,
      "headline": "Incyte (INCY) Surpasses Q2 Earnings and Revenue Estimates",
      "id": 136119871,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Incyte (INCY) delivered earnings and revenue surprises of +12.95% and +5.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=76cf5b8634ecb133114ed0095071805ccbdfa884589707a7d3b8281f914940cb"
    }
  },
  {
    "ts": null,
    "headline": "Incyte (NASDAQ:INCY) Reports Strong Q2",
    "summary": "Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) announced better-than-expected revenue in Q2 CY2025, with sales up 16.5% year on year to $1.22 billion. Its non-GAAP profit of $1.57 per share was 6.5% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=efeb775bbd5efa8e809c6870939ecacf371c05863a3d8ae18bc3bb741f0ace9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753789697,
      "headline": "Incyte (NASDAQ:INCY) Reports Strong Q2",
      "id": 136117408,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) announced better-than-expected revenue in Q2 CY2025, with sales up 16.5% year on year to $1.22 billion. Its non-GAAP profit of $1.57 per share was 6.5% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=efeb775bbd5efa8e809c6870939ecacf371c05863a3d8ae18bc3bb741f0ace9a"
    }
  },
  {
    "ts": null,
    "headline": "Incyte: Q2 Earnings Snapshot",
    "summary": "WILMINGTON, Del. AP) — Incyte Corp. INCY) on Tuesday reported second-quarter net income of $405 million.",
    "url": "https://finnhub.io/api/news?id=737984a8577a16619f6bf2bc30a70fac3ee5f5e1e7db953d07e52863b2c0d07b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753787692,
      "headline": "Incyte: Q2 Earnings Snapshot",
      "id": 136117409,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "WILMINGTON, Del. AP) — Incyte Corp. INCY) on Tuesday reported second-quarter net income of $405 million.",
      "url": "https://finnhub.io/api/news?id=737984a8577a16619f6bf2bc30a70fac3ee5f5e1e7db953d07e52863b2c0d07b"
    }
  },
  {
    "ts": null,
    "headline": "Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs",
    "summary": "WILMINGTON, Del., July 29, 2025--Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs",
    "url": "https://finnhub.io/api/news?id=190ef04c2bb14337b9363a657a47aba31b98977e03970a877d30ab649a67041a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753786800,
      "headline": "Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs",
      "id": 136117410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "WILMINGTON, Del., July 29, 2025--Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs",
      "url": "https://finnhub.io/api/news?id=190ef04c2bb14337b9363a657a47aba31b98977e03970a877d30ab649a67041a"
    }
  },
  {
    "ts": null,
    "headline": "Incyte 2Q Net Up on Rev Growth, Boosts 2025 Cancer-Drug Rev Views",
    "summary": "Incyte 2Q Net Up on Rev Growth, Boosts 2025 Cancer-Drug Rev Views",
    "url": "https://finnhub.io/api/news?id=ead8e6687c763380fba026ebd3f27f4a60f70264eb738e11d39f62005f8a1276",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753776720,
      "headline": "Incyte 2Q Net Up on Rev Growth, Boosts 2025 Cancer-Drug Rev Views",
      "id": 137153476,
      "image": "",
      "related": "INCY",
      "source": "MarketWatch",
      "summary": "Incyte 2Q Net Up on Rev Growth, Boosts 2025 Cancer-Drug Rev Views",
      "url": "https://finnhub.io/api/news?id=ead8e6687c763380fba026ebd3f27f4a60f70264eb738e11d39f62005f8a1276"
    }
  }
]